Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mira

Showing results (151-160 of 209) with videos related to

Pageof 21
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|May 1, 2012
[Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain]Celia Cifuentes, José A Mira, Julio Vargas, et al.
BMJ Open|March 21, 2023
Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation studyTurki Abdulaziz Althunian, Meshael M Alrasheed, Fatemah A Alnofal, et al.
Cryo Letters|January 10, 2023
Cryoprotection of humanin-like peptides in seminal plasma for ejaculated spermatozoa of crossbred bullsM Pande, S K Ghosh, S Tyagi, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 5, 2013
Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patientsJuan Macías, Antonio Rivero, Celia Cifuentes, et al.
Infection|October 16, 2012
Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBVA Rivero-Juarez, J A Mira, A Camacho, et al.
The American Journal of Tropical Medicine and Hygiene|March 20, 2004
Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapyJose A Mira, Juan E Corzo, Antonio Rivero, et al.
The Journal of Antimicrobial Chemotherapy|March 19, 2011
Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patientsAntonio Rivero-Juárez, José A Mira, Inés Pérez-Camacho, et al.
Actas Urologicas Espanolas|January 1, 1987
[Renal oncocytoma: presentation of a case and review of the literature]J Lobato Encinas, M J Mayol Belda, J Megias Garrigos, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 6, 2011
Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatmentK Neukam, J A Mira, I Gilabert, et al.
Antiviral Therapy|August 17, 2010
Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosineNicolás Merchante, Inés Pérez-Camacho, José A Mira, et al.
Pageof 21

Showing results (151-160 of 209) with videos related to

Sort By:
Pageof 21
Enfermedades Infecciosas Y Microbiologia Clinica|May 1, 2012
[Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain]Celia Cifuentes, José A Mira, Julio Vargas, et al.
BMJ Open|March 21, 2023
Recording type 2 diabetes mellitus in a standardised central Saudi database: a retrospective validation studyTurki Abdulaziz Althunian, Meshael M Alrasheed, Fatemah A Alnofal, et al.
Cryo Letters|January 10, 2023
Cryoprotection of humanin-like peptides in seminal plasma for ejaculated spermatozoa of crossbred bullsM Pande, S K Ghosh, S Tyagi, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 5, 2013
Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patientsJuan Macías, Antonio Rivero, Celia Cifuentes, et al.
Infection|October 16, 2012
Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBVA Rivero-Juarez, J A Mira, A Camacho, et al.
The American Journal of Tropical Medicine and Hygiene|March 20, 2004
Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapyJose A Mira, Juan E Corzo, Antonio Rivero, et al.
The Journal of Antimicrobial Chemotherapy|March 19, 2011
Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patientsAntonio Rivero-Juárez, José A Mira, Inés Pérez-Camacho, et al.
Actas Urologicas Espanolas|January 1, 1987
[Renal oncocytoma: presentation of a case and review of the literature]J Lobato Encinas, M J Mayol Belda, J Megias Garrigos, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 6, 2011
Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatmentK Neukam, J A Mira, I Gilabert, et al.
Antiviral Therapy|August 17, 2010
Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosineNicolás Merchante, Inés Pérez-Camacho, José A Mira, et al.
Pageof 21